Estrogenic compounds as anti-mitotic agents

Details Estrogenic compounds as anti-mitotic agents Estrogenic compounds as anti-mitotic agents

2006-03-14

2006-03-14

Badio, Barbara P. (Department: 1616)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

Reexamination Certificate

active

07012070

ABSTRACT:
The application discloses methods of treating mammalian diseases characterized by abnormal cell mitosis by administering estradiol derivatives including those comprising colchicine or combretastatin A-4 structural motifs of the general formulae found below in a dosage sufficient to inhibit cell mitosis. The application discloses novel compounds used in the methods.

REFERENCES:
patent: 2584271 (1952-02-01), Huffman
patent: 2846453 (1958-08-01), Hoehn
patent: 3166577 (1965-01-01), Ringold et al.
patent: 3410879 (1968-11-01), Smith et al.
patent: 3470218 (1969-09-01), Farah
patent: 3492321 (1970-01-01), Crabbe
patent: 3496272 (1970-02-01), Kruger
patent: 3562260 (1971-02-01), De Ruggieri et al.
patent: 3956348 (1976-05-01), Hilscher
patent: 4172132 (1979-10-01), Draper et al.
patent: 4212864 (1980-07-01), Tax
patent: 4307086 (1981-12-01), Tax
patent: 4444767 (1984-04-01), Torelli et al.
patent: 4522758 (1985-06-01), Ward et al.
patent: 4552758 (1985-11-01), Murphy et al.
patent: 4634705 (1987-01-01), DeBernardis et al.
patent: 4743597 (1988-05-01), Javitt et al.
patent: 4808402 (1989-02-01), Leibovich et al.
patent: 4994443 (1991-02-01), Folkman et al.
patent: 5001116 (1991-03-01), Folkman et al.
patent: 5135919 (1992-08-01), Folkman et al.
patent: 5504074 (1996-04-01), D'Amato et al.
patent: 5621124 (1997-04-01), Seilz et al.
patent: 5643900 (1997-07-01), Fotsis et al.
patent: 5661143 (1997-08-01), D'Amato
patent: 5892069 (1999-04-01), D'Amato et al.
patent: 6011023 (2000-01-01), Clark et al.
patent: 6528676 (2003-03-01), D'Amato et al.
patent: 2002/0119959 (2002-08-01), D'Amato et al.
patent: 2002/0165212 (2002-11-01), D'Amato et al.
patent: 1907330 (1969-10-01), None
patent: 3625315 (1988-01-01), None
patent: 0166937 (1986-08-01), None
patent: 857080 (1960-12-01), None
patent: 857081 (1960-12-01), None
patent: 1570597 (1980-07-01), None
patent: 39-5480 (1964-04-01), None
patent: 41 000100 (1966-01-01), None
patent: 42-928 (1967-01-01), None
patent: 58-131978 (1983-08-01), None
patent: 63090763 (1988-04-01), None
patent: 63-119500 (1988-05-01), None
patent: 1240038 (1996-10-01), None
patent: WO 87/02367 (1987-04-01), None
patent: WO 88/08002 (1988-10-01), None
patent: WO 90/15816 (1990-12-01), None
patent: WO 93/03729 (1993-03-01), None
patent: WO 93/19746 (1993-10-01), None
patent: WO 95/04535 (1995-02-01), None
Seegers et al., “The cytotoxic effects of estradiol-17beta catecholestradiols and methoxyestradiol on dividing MCF-7 and HeLa cells.” J. Steroid Biochem., vol. 32(6), pp. 797-809, 1989.
Research Plus Catalogpp. 50-58, 1993.
U.S. Appl. No. 09/779,331, filed Feb. 8, 2001, entitled “Antiangiogenic Agents”.
U.S. Appl. No. 10/077,142, filed Feb. 15, 2002, entitled “Estrogenic Compounds as Anti-Mitotic Agents”.
U.S. Appl. No. 09/866,279, filed May 25, 2001, entitled “Use of Estrogenic Compounds as Anti-Fungal Agents”.
U.S. Appl. No. 09/899,702, filed Jul. 5, 2001, entitled “Estrogenic Compounds as Antiangiogenic Agents”.
U.S. Appl. No. 09/939,208, filed Aug. 24, 2001, entitled “Antiangiogenic Agents”.
Adams, E.F. et al., Steroidal regulation of oestradiol-17B dehydrogenase activity of the human breast cancer cell line MCF-7 (Chemical Abstracts Doc. No. 109:32325, 1988),Journal of Endocrinology, vol. 118(1), pp. 149-154, Jul. 1988.
Bhat et al., Estradiol-induced Mitotic Inhibition in the Bursa of Fabricius of Male Domestic Duckling (Chemical Abstracts Doc. No. 98:31837, 1982),Mikroskopie, vol. 39, pp. 113-117, May 1982.
Blickenstaff et al., Estrogen-Catharanthus (Vinca) Alkaloid Conjugates (Chemical Abstracts Doc. No.: 94:114277, 1981),Cytotoxic Estrogens in Hormone Receptive Tumors, pp. 89-105, 1980.
Boye et al., 185, Deaminocolchinyl Methyl Ether: Synthesis from 2,3,4,4′-Tetramethoxybiphenyl- 2-carbaldehyde. Comparison of Antitubulin Effects of Deaminocolchinyl Methyl Ether and Dehydro Analogs,Helvetica Chimica Acta, vol. 72, pp. 1690-1696, 1989.
Crum, R., et al., A New Class of Steroids Inhibits Angiogenesis in the Presence of Heparin or a Heparin Fragment,Science, vol. 230, pp. 1375-1378, Dec. 20, 1985.
Evans et al., A Convergent Total Synthesis of +/− Colchicine and +/− Desacetamidoisocolchicine,Journal of the American Chemical Society, vol. 103, pp. 5813-5821, Sep. 23, 1981.
Fitzgerald, Molecular Features of Colchicine Associated with Antimitotic Activity and Inhibition of Tubulin Polymerization,Biochemical Pharmacology, vol. 25(12), pp. 1383-1387, Jun. 15, 1976.
Getahun et al., Synthesis of Alkoxy-Substituted Diaryl Compounds and Correlation of Ring Separation with Inhibition of Tubulin Polymerization: Differential Enhancement of Inhibitory Effects Under Suboptimal Polymerization Reaction Conditions,Journal of Medicinal Chemistry, vol. 35(6), pp. 1058-1067, Mar. 20, 1992.
Gross et al., Inhibition of Tumor Growth, Vascularization, and Collagenolysis in the Rabbit Cornea by Medroxyprogesterone,Procedings of the National Academy of Science USA, vol. 78(2), pp. 1176-1180, Feb. 1981.
Hartley-ASP et al. Diethylstilbestrol Induces Metaphase Arrest and Inhibits Microtubule Assembly,Mutation Research, vol. 143(4), pp. 231-235, Aug. 1985.
Huber et al., Tubulin Binding of Conformationally Restricted Bis-Aryl Compounds,Bioorganic&Medicinal Chemistry Letters, vol. 1(5), pp. 243-246, 1991.
Lin et al., Interactions of Tubulin with Potent Natural and Synthetic Analogs of the Antimitotic Agent Combretastatin: A Structure-Activity Study,Molecular Pharmacology, vol. 34(2), pp. 200-208, Aug. 1988.
Lincoln et al., Conformation of Thiocolchicine and Two B-Ring-Modified Analogues Bound to Tubulin Studied with Optical Spectroscopy,Biochemistry, vol. 30(5), pp. 1179-1187, Feb. 5, 1991.
Lottering et al., Effects of the 17β-Estradiol Metabolites on Cell Cycle Events in MCF-7 Cells (Chemical Abstracts Doc. No.: 117:245769, 1992),Cancer Research, vol. 52, pp. 5926-5932, Nov. 1, 1992.
Morgan et al., Calcium and Oestrogen Interactions upon the Rat Thymic Lymphocyte Plasma Membrane (Chemical Abstracts Doc. No.: 85:172052, 1976),Biochemical and Biophysical Research Communications, vol. 72(2), pp. 663-672, Sep. 20, 1976.
Mukundan et al., Liver Regeneration in Oral Contraceptive Treated Female Rats—Effects of Moderate Malnutrition (Chemical Abstracts Doc. No.: 102:143342, 1984),Hormone and Metabolic Research, vol. 16(12), pp. 641-645, Dec. 1984.
Nakamura et al., Studies on the Total Synthesis ofdl-Colchiceine. I. Synthesis of 3-Hydroxy-9, 10, 11-trimethoxy-1,2,3,4,6,7-hexahydro-5H-dibenzo[a,c] cycloheptatrien-5-one,Chemical and Pharmaceutical Bulletin, vol. 10, pp. 281-290, 1962.
Oppolzer et al., 177. The Enantioselective Synthesis of (+)-Estradiol from 1,3-Dihydrobenzo[c] thiophene-2,2-dioxide by Successive Thermal SO2-Extrusion and Cycloaddition Reactions,Helvetica Chimica Acta, vol. 63, pp. 1703-1705, 1980.
Paull et al., Identification of Novel Antimitotic Agents Acting at the Tubulin Level by Computer-assisted Evaluation of Differential Cytotoxicity Data,Cancer Research, vol. 52(14), pp. 3892-3900, Jul. 15, 1992.
Poli et al., Tumor Necrosis Factor α Functions in an Autocrine Manner in the Induction of Human Immunodeficiency Virus Expression,Proceedings of the National Academy of Science USA, vol. 87(2), pp. 782-785, Jan. 1990.
Rao et al., Structural Specificity of Estrogens in the Induction of Mitotic Chromatid Non-Disjunction in Hela Cells,Experimental Cell Research, vol. 48, pp. 71-81, 1967.
Ravindra, R., Effect of Estradiol on thein vitro Assembly of Rat Brain Tubulin,Journal of Indian Institute of Science, vol. 64(3), pp. 27-35, Mar. 1983.
Sakakibara et al., Effects of Diethylstilbestrol and its Methl Ethers on Aneuploidy Induction and Microtubule Distribution in Chinese Hamster V79 cells,Mutation Research, vol. 263(4), pp. 269-276, Aug. 1991.
Sato et al., Effect of Estradiol and Ethynylestradiol on Microtubule Distribution in Chinese Hamster V79 Cells,Chemical and Pharmaceutical Bulletin, vol. 40(1), pp. 182-184, Jan. 1992.
Sato et al., Disruptive Effect of Diethylst

Affiliated with

Also associated with

Rating

Estrogenic compounds as anti-mitotic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Estrogenic compounds as anti-mitotic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrogenic compounds as anti-mitotic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3576344